BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1719259)

  • 1. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
    Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
    Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
    Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
    N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
    Takahashi S; Okamoto SI; Shirafuji N; Ikebuchi K; Tani K; Shimane M; Matsudaira T; Irie S; Tsuruta T; Matsuishi E
    Bone Marrow Transplant; 1994 Mar; 13(3):239-45. PubMed ID: 7515298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group.
    Dombret H; Chastang C; Fenaux P; Reiffers J; Bordessoule D; Bouabdallah R; Mandelli F; Ferrant A; Auzanneau G; Tilly H
    N Engl J Med; 1995 Jun; 332(25):1678-83. PubMed ID: 7539109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application of recombinant human colony-stimulating factor (rhG-CSF) in bone marrow transplantation].
    Takahashi S; Kodo H
    Rinsho Ketsueki; 1990 May; 31(5):589-96. PubMed ID: 1697628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders.
    Shirafuji N; Asano S; Matsuda S; Watari K; Takaku F; Nagata S
    Exp Hematol; 1989 Feb; 17(2):116-9. PubMed ID: 2463930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of rhG-CSF (KRN8601) in patients with myelodysplastic syndrome].
    Toyama K; Ohyashiki J; Takaku F; Kobayashi Y; Miyazono K; Miura Y; Sakamoto S; Mizoguchi H; Hoshino S; Urabe A
    Rinsho Ketsueki; 1990 Jul; 31(7):937-45. PubMed ID: 1699007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor in acute myeloid leukemia.
    Usuki K; Iki S; Endo M; Kitazume K; Ito K; Watanabe M; Urabe A
    Stem Cells; 1995 Nov; 13(6):647-54. PubMed ID: 8590866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of aplastic anemia with KRN8601 (rhG-CSF)].
    Kojima S; Matsuyama T; Miyazaki T; Sakurada K; Shike S; Okino E; Akabane T; Nakahata T; Okuni M; Mugishima H
    Rinsho Ketsueki; 1990 Jul; 31(7):929-36. PubMed ID: 1699006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
    Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
    Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of recombinant human granulocyte colony stimulating factor in children with acute myeloid leukemia.
    Shang X; Yin H; Lu A; Zhang L
    Chin Med J (Engl); 1999 Jul; 112(7):620-2. PubMed ID: 11601256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia.
    Zhang WG; Wang FX; Chen YX; Cao XM; He AL; Liu J; Ma XR; Zhao WH; Liu SH; Wang JL
    Am J Hematol; 2008 Mar; 83(3):185-8. PubMed ID: 17899614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.